Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Handling of Rejects and Recalls

Posted on By

SOP for Handling of Rejects and Recalls

Standard Operating Procedure for Handling of Rejects and Recalls in Vaginal Dosage Form Manufacturing

1) Purpose

The purpose of this SOP is to establish guidelines for the identification, handling, and disposition of rejected products and the management of recalls in the manufacturing of vaginal dosage forms.

2) Scope

This SOP applies to all personnel involved in the manufacturing, quality control, and quality assurance departments at [Company Name] responsible for handling rejects and recalls.

3) Responsibilities

Quality Assurance (QA) is responsible for overseeing the process of handling rejects and recalls. Production and Quality Control (QC) departments are responsible for implementing actions outlined in this SOP.

See also  SOP for Gel Storage Unit

4) Procedure

4.1 Identification of Rejects

  1. Rejects are identified during in-process checks, final testing, or post-production inspection.
  2. Clearly label and segregate rejected products from acceptable batches.

4.2 Documentation and Reporting

  1. Document details of rejected batches including reasons for rejection, quantity, and batch number.
  2. Report rejects to QA for review and approval of further actions.

4.3 Disposition of Rejects

  1. Dispose of rejected products as per approved procedures (e.g., destruction, reprocessing).
  2. Ensure proper documentation of disposal activities.

4.4 Recall Management

  1. Initiate recall procedures promptly upon identification of a potential issue that may impact product quality or safety.
  2. Coordinate with regulatory affairs and communicate with relevant stakeholders (e.g., customers, regulatory authorities).
See also  SOP for Deviations and Corrective Actions

4.5 Corrective and Preventive Actions (CAPA)

  1. Investigate root causes of rejects and recalls.
  2. Implement CAPAs to prevent recurrence of similar issues.

5) Abbreviations, if any

QA: Quality Assurance; QC: Quality Control; SOP: Standard Operating Procedure; CAPA: Corrective and Preventive Actions

6) Documents, if any

Reject handling form, Recall initiation form, CAPA form

7) Reference, if any

ICH Q9: Quality Risk Management, WHO Technical Report Series No. 996, Annex 5: Guidelines on Good Manufacturing Practices for Sterile Pharmaceutical Products

8) SOP Version

Version 1.0

Vaginal Dosage Forms Tags:Audit trail SOP for vaginal dosage forms, Batch record review SOP for vaginal formulations, Batch release procedure for vaginal gels, Change control SOP for vaginal products, Cleaning validation SOP for vaginal equipment, Complaint handling SOP for vaginal products, Deviation handling SOP for vaginal dosage forms, Documentation control SOP for vaginal SOPs, environmental monitoring in vaginal manufacturing, Filling suppositories, GMP SOP for vaginal gel manufacturing, Labeling SOP for vaginal medicines, Mixing SOP for vaginal formulations, Packaging SOP for vaginal dosage forms, Procedure for vaginal ring production, Process validation SOP for vaginal preparations, Quality control SOP for vaginal tablets, Risk assessment SOP for vaginal manufacturing, SOP for emergency response in vaginal production, SOP for filling vaginal suppositories, SOP for vaginal cream formulation, SOP for vaginal dosage forms, SOP for vaginal medications, SOP for vaginal production, Stability testing SOP for vaginal rings, Sterility testing SOP for vaginal products, Suppository SOP, Training program for vaginal product manufacturing, Vaginal suppository manufacturing SOP, Vaginal tablet production guidelines, Validation protocol for vaginal creams, Vendor qualification SOP for vaginal ingredients

Post navigation

Previous Post: SOP for Roller Compaction in Granules Production
Next Post: SOP for Aseptic Filling Machine

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version